Gene · 5686
Papers689
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 689
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PSMA1, PSMA5, and PSMB2 serve as prognostic biomarkers and are correlated with tumor-infiltrating leukocytes in HCC. | Epigenetics | 2026 | 42735232 | PubTator, text mining | PubMed |
| Exosomal gene-based predictive model and therapeutic target identification for Alzheimer's disease: A bioinformatics analysis. | PLoS One | 2026 | 42475384 | PubTator, text mining | PubMed |
| Sarcomatoid Renal Cell Carcinoma: Biological Features and Therapeutic Implications-A Narrative Review. | Curr Urol Rep | 2026 | 41792526 | PubTator, text mining | PubMed |
| Ubiquitin-proteasome system dysregulation in FAM111B-related poikiloderma and phenotypic spectrum expansion: new case reports and long-term follow-up. | EBioMedicine | 2025 | 40840166 | PubTator, text mining | PubMed |
| Development and validation of G2M signature-based prognostic model for stratifying colon cancer prognosis. | Discov Oncol | 2025 | 40783878 | PubTator, text mining | PubMed |
| PSMA5 as a modulator of glioblastoma senescence and prognosis. | BMC Cancer | 2025 | 40597008 | PubTator, text mining | PubMed |
| Brain and blood transcriptome-wide association studies identify five novel genes associated with Alzheimer's disease. | J Alzheimers Dis | 2025 | 40111921 | PubTator, text mining | PubMed |
| Are cities under bright lights more innovative? Evidence from China. | Heliyon | 2024 | 39253158 | PubTator, text mining | PubMed |
| Unveiling the role of PSMA5 in glioma progression and prognosis. | Discov Oncol | 2024 | 39240463 | PubTator, text mining | PubMed |
| Role and mechanism of IRF9 in promoting the progression of rheumatoid arthritis by regulating macrophage polarization via PSMA5. | Heliyon | 2024 | 39170377 | PubTator, text mining | PubMed |
| Causal associations between chronic heart failure and the cerebral cortex: results from Mendelian randomization study and integrated bioinformatics analysis. | Front Cardiovasc Med | 2024 | 39027007 | PubTator, text mining | PubMed |
| Tissue-specific gene expression of genome-wide significant loci associated with major depressive disorder subtypes. | Prog Neuropsychopharmacol Biol Psychiatry | 2024 | 38663672 | PubTator, text mining | PubMed |
| Knockdown of liver cancer cell-secreted exosomal PSMA5 controls macrophage polarization to restrain cancer progression by blocking JAK2/STAT3 signaling. | Immun Inflamm Dis | 2024 | 38415977 | PubTator, text mining | PubMed |
| Investigating the Potential Shared Molecular Mechanisms between COVID-19 and Alzheimer's Disease via Transcriptomic Analysis. | Viruses | 2024 | 38257800 | PubTator, text mining | PubMed |
| Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides. | Int J Mol Sci | 2024 | 38256007 | PubTator, text mining | PubMed |
| An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer. | BMC Womens Health | 2024 | 38238671 | PubTator, text mining | PubMed |
| Single-cell and transcriptomic analyses reveal the influence of diabetes on ovarian cancer. | BMC Genomics | 2024 | 38166541 | PubTator, text mining | PubMed |
| Blood Plasma Circulating DNA-Protein Complexes: Involvement in Carcinogenesis and Prospects for Liquid Biopsy of Breast Cancer. | J Pers Med | 2023 | 38138918 | PubTator, text mining | PubMed |
| Multi-level characteristics recognition of cancer core therapeutic targets and drug screening for a broader patient population. | Front Pharmacol | 2023 | 38074121 | PubTator, text mining | PubMed |
| Vitreous Humor Proteomic Profile in Patients With Vitreoretinal Lymphoma. | Invest Ophthalmol Vis Sci | 2023 | 38038618 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5686/papers